12.27
Coeptis Therapeutics Holdings Inc Azioni (COEP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
219.18%
0.2007
|
0.0629 | - | - | - |
Cost Of Revenue |
0.00%
0.0452
|
0.0452 | - | - | - |
Gross Profit |
777.77%
0.1555
|
0.0177 | - | - | - |
|
14.77%
4.6767
|
4.0747 | 2.1622 | 2.1418 | 2.8281 |
Benefits Costs and Expenses |
30.18%
4.5353
|
3.4838 | - | - | - |
Costs And Expenses |
30.18%
4.5353
|
3.4838 | - | - | - |
Depreciation and Amortization |
0.00%
0.25
|
0.25 | 0.25 | 0.25 | 0.25 |
Operating Income/Loss |
11.44%
-4.5212
|
-4.057 | -2.1622 | -2.1418 | -2.8281 |
Nonoperating Income/Loss |
70.66%
0.1866
|
0.636 | -0.8496 | 0.3129 | -0.2072 |
Income/Loss From Continuing Operations Before Tax |
26.71%
-4.3346
|
-3.4209 | -3.0118 | -1.8289 | -3.0353 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
15.60%
-3.5346
|
-3.0577 | -1.948 | -1.8289 | -3.0353 |
|
3.32%
-3.5346
|
-3.4209 | -1.948 | -1.8289 | -3.0353 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
120.26%
0.80
|
0.3632 | 1.0638 | - | - |
Basic Average Shares |
20.62%
3.7068
|
3.0731 | -35.72 | 39.81 | 37.57 |
Diluted Average Shares |
20.62%
3.7068
|
3.0731 | -35.72 | 39.81 | 37.57 |
Basic Earnings Per Share |
5.41%
-1.17
|
-1.11 | -5.44 | -0.05 | -0.08 |
Diluted Earnings Per Share |
5.41%
-1.17
|
-1.11 | -5.44 | -0.05 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):